GO:1904890 negative regulation of excitatory synapse assembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904890 describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of excitatory synapse assembly.
• Excitatory synapse assembly is a tightly controlled process; its negative regulation is essential for proper neural circuit formation and function.
• Key molecular players include GluN3A-containing NMDA receptors, GIT1, mTORC1, PICK1, and Shank1, which modulate synapse formation and maturation [2, 4, 5].
• Dysregulation of negative regulation of excitatory synapse assembly is implicated in Alzheimer's disease and other neurological disorders.
• CRISPR-based approaches (knockout, point mutation, knock-in, overexpression) enable precise dissection of genes controlling this process [2, 5].
• Understanding GO:1904890 provides insights into synaptic plasticity, memory, and potential therapeutic targets for synaptopathies [2, 3].
Description
Excitatory synapses are the primary sites of information transfer in the brain, and their assembly must be precisely regulated to ensure proper neural circuit formation. GO:1904890, negative regulation of excitatory synapse assembly, encompasses any process that stops, prevents, or reduces the frequency, rate, or extent of excitatory synapse assembly. This regulatory mechanism is critical for balancing synaptogenesis and synaptic pruning during development and for maintaining synaptic homeostasis in the adult brain. Disruption of this balance can lead to neurological disorders, including Alzheimer's disease and epilepsy [3, 8]. Researchers studying this term aim to identify the molecular brakes that limit excitatory synapse formation, offering potential targets for therapeutic intervention in synaptopathies [2, 5].
negative regulation of excitatory synapse assembly At A Glance
| GO ID | GO:1904890 |
|---|---|
| GO term | negative regulation of excitatory synapse assembly |
| Ontology | biological_process |
| Synonym | down regulation of excitatory synapse assembly; inhibition of excitatory synapse formation |
| Major function | Limits the number and strength of excitatory synapses during development and plasticity |
| Related processes | Synaptic pruning, synaptic plasticity, neural circuit formation |
| Key regulators | GluN3A-NMDA receptors, GIT1, mTORC1, PICK1, Shank1 |
| Disease relevance | Alzheimer's disease, epilepsy, neurodevelopmental disorders |
What Is GO:1904890?
GO:1904890 is a biological process term defined as any process that stops, prevents, or reduces the frequency, rate, or extent of excitatory synapse assembly. It includes mechanisms that inhibit the formation of excitatory synapses, such as the stabilization of immature spines, the removal of synaptic proteins, or the active suppression of synaptogenic signaling pathways.
Why Is negative regulation of excitatory synapse assembly Important in Cell Biology?
Negative regulation of excitatory synapse assembly is essential for normal brain function because it prevents excessive excitatory connectivity, which can lead to excitotoxicity, seizures, and cognitive deficits. This process also allows for experience-dependent refinement of neural circuits, enabling adaptive behaviors and memory formation [2, 3].
• Prevents hyperexcitability and excitotoxicity by limiting synapse number.
• Enables synaptic pruning during development for efficient neural circuits.
• Modulates synaptic plasticity and memory formation.
• Dysregulation is linked to Alzheimer's disease and cognitive decline.
• Involved in epilepsy susceptibility through AMPA and kainate receptor regulation.
• Provides targets for therapeutic intervention in synaptopathies.
• Helps maintain balance between excitation and inhibition.
• Regulates dendritic spine morphology and stability.
• Contributes to the pathophysiology of phenylketonuria-associated brain dysfunction.
• Offers insights into neurodevelopmental disorders such as autism spectrum disorders.
What Happens During negative regulation of excitatory synapse assembly?
Inhibition of Synaptogenic Signaling
In simple terms: The cell applies brakes to signals that promote synapse formation.
Negative regulation of excitatory synapse assembly often involves the suppression of pro-synaptogenic pathways. For example, GluN3A-containing NMDA receptors inhibit the assembly of GIT1/mTORC1 complexes, thereby reducing protein synthesis required for synapse formation. This inhibition limits the number of excitatory synapses during development and in response to activity.
Removal or Destabilization of Synaptic Proteins
In simple terms: Proteins that hold synapses together are removed or broken down.
The stability of excitatory synapses depends on scaffolding proteins such as Shank1 and PICK1. Negative regulation can occur through the degradation or removal of these proteins. For instance, Shank1 mRNA transport and translation are controlled by its 5' untranslated region, affecting the availability of Shank1 protein at synapses. PICK1 mediates synaptic recruitment of AMPA receptors, and its downregulation reduces excitatory synapse strength.
Regulation of Dendritic Spine Morphology
In simple terms: The physical shape of dendritic spines is altered to limit synapse formation.
Dendritic spines are the postsynaptic sites of most excitatory synapses. Negative regulation of excitatory synapse assembly can involve changes in spine morphology, such as spine shrinkage or retraction. Fhod3, an actin-binding protein, controls dendritic spine morphology in specific pyramidal neuron subpopulations, and its activity can restrict synapse assembly.
Activity-Dependent Synaptic Pruning
In simple terms: Active synapses are strengthened while inactive ones are eliminated.
During development, negative regulation of excitatory synapse assembly contributes to activity-dependent pruning, where less active synapses are eliminated. This process is influenced by GABAergic signaling, which can regulate adult hippocampal neurogenesis and synapse integration. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease also involves aberrant pruning mechanisms.
Key Genes Involved in GO:1904890 negative regulation of excitatory synapse assembly
The following genes and proteins have been experimentally linked to the negative regulation of excitatory synapse assembly.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GRIN3A | Encodes GluN3A subunit of NMDA receptors; inhibits GIT1/mTORC1 assembly | Regulates protein synthesis and memory; target for cognitive disorders |
| GIT1 | Scaffold protein in mTORC1 assembly; promotes protein synthesis | Its inhibition by GluN3A reduces synapse formation |
| MTOR | Kinase in mTORC1 complex; controls translation | Central to synaptogenic signaling; modulated by GluN3A |
| SHANK1 | Postsynaptic scaffold protein; organizes glutamate receptors | mRNA transport and translation control affect synapse stability |
| PICK1 | Adaptor protein; recruits AMPA receptors to synapses | Mediates synaptic recruitment; downregulation reduces excitatory synapses |
| FHOD3 | Actin-binding protein; regulates spine morphology | Controls dendritic spine shape in pyramidal neurons |
| CLMP | Adhesion molecule; regulates AMPA and kainate receptor responses | Modulates seizure susceptibility in neonatal hippocampus |
| GRIN1 | Essential NMDA receptor subunit | Component of NMDA receptors involved in synapse regulation |
| GRIN2A | NMDA receptor subunit | Modulates synaptic plasticity and excitotoxicity |
| GRIN2B | NMDA receptor subunit | Involved in developmental synapse regulation |
| DLG4 | PSD-95 scaffold protein | Organizes postsynaptic density; target for synapse regulation |
| HOMER1 | Postsynaptic scaffold | Links mGluRs to NMDA receptors; affects synapse stability |
| ARC | Activity-regulated cytoskeleton-associated protein | Involved in synaptic plasticity and AMPA receptor trafficking |
| CAMK2A | Calcium/calmodulin-dependent kinase II | Key regulator of synaptic plasticity and spine morphology |
| BDNF | Neurotrophin | Promotes synapse formation; its negative regulation limits excitatory synapses |
| GABRA1 | GABA-A receptor subunit | Mediates inhibitory signaling that can negatively regulate excitatory synapse assembly |
| GABRB2 | GABA-A receptor subunit | Modulates inhibitory tone and neurogenesis |
| GABRG2 | GABA-A receptor subunit | Involved in inhibitory control of synapse assembly |
How Is negative regulation of excitatory synapse assembly Regulated?
The negative regulation of excitatory synapse assembly is itself tightly regulated. GluN3A-containing NMDA receptors act as a brake on synaptogenesis by inhibiting the assembly of GIT1/mTORC1 complexes, thereby reducing protein synthesis needed for synapse formation. This regulation is activity-dependent and can be modulated by neurotransmitters such as GABA, which influences adult hippocampal neurogenesis and synaptic integration. Additionally, the availability of scaffolding proteins like Shank1 is controlled at the level of mRNA transport and translation, and PICK1-mediated AMPA receptor recruitment can be dynamically regulated. These layers of control ensure that excitatory synapse assembly is precisely tuned to developmental and activity cues.
negative regulation of excitatory synapse assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GRIN3A | Alzheimer's disease, cognitive disorders | Knockout or overexpression in mouse models; point mutations to disrupt GIT1 binding |
| CLMP | Epilepsy, seizure susceptibility | Knockout mice; kainate-induced seizure models |
| SHANK1 | Autism spectrum disorders, neurodevelopmental disorders | Knockout mice; knock-in of patient mutations |
| PICK1 | Synaptic dysfunction, neurodevelopmental disorders | Knockout mice; point mutations affecting AMPA receptor binding |
| FHOD3 | Dendritic spine morphology, cognitive disorders | Conditional knockout; overexpression in pyramidal neurons |
Alzheimer's Disease
Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease involves synaptic loss and aberrant network activity. Negative regulation of excitatory synapse assembly may be pathologically enhanced, contributing to synapse elimination and cognitive decline. Understanding this process could reveal therapeutic targets to preserve synapses.
Epilepsy and Seizure Susceptibility
Dysregulation of excitatory synapse assembly can lead to hyperexcitability and seizures. CLMP regulates AMPA and kainate receptor responses in the neonatal hippocampus, and its disruption affects kainate seizure susceptibility in mice. Proper negative regulation is thus critical for maintaining excitation-inhibition balance.
Neurodevelopmental Disorders
Alterations in genes controlling synapse assembly, such as SHANK1 and PICK1, have been linked to neurodevelopmental disorders including autism spectrum disorders. Negative regulation of excitatory synapse assembly ensures appropriate synaptic connectivity, and its disruption may contribute to these conditions [4, 5].
Phenylketonuria (PKU)
In a mouse model of phenylketonuria, gene expression profiles in the brain are altered, and low phenylalanine diet therapy reverses some changes. These alterations may impact synaptic assembly and function, highlighting the importance of negative regulation in metabolic brain disorders.
From negative regulation of excitatory synapse assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GRIN3A increase excitatory synapse number? | GRIN3A knockout mouse or CRISPR knockout in neurons |
| Does a point mutation in GIT1 that prevents mTORC1 binding affect synapse assembly? | Knock-in mouse expressing GIT1 mutant |
| How does PICK1 phosphorylation regulate AMPA receptor recruitment? | Point mutation at phosphorylation sites; knock-in mice |
| What is the effect of Shank1 5'UTR mutations on dendritic transport? | Knock-in of mutated 5'UTR; reporter assays |
| Can overexpression of Fhod3 rescue spine morphology defects? | Overexpression via viral vectors in knockout background |
| Does CLMP knockout alter seizure susceptibility? | CLMP knockout mice; kainate seizure induction |
How to Study the negative regulation of excitatory synapse assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Excitatory postsynaptic currents (EPSCs) | Quantify synapse strength and number [2, 5] |
| Confocal/two-photon microscopy | Dendritic spine density and morphology | Assess structural changes in synapse assembly |
| RNA sequencing | Transcriptomic changes | Identify gene expression alterations in disease models |
| Co-immunoprecipitation | Protein-protein interactions | Study complex formation like GluN3A-GIT1-mTORC1 |
| Western blotting | Protein expression levels | Validate knockout or overexpression efficiency |
| Immunohistochemistry | Protein localization in tissue | Examine synaptic protein distribution |
| Behavioral assays | Memory and learning | Link synapse regulation to cognitive function |
| Seizure induction | Seizure susceptibility | Assess hyperexcitability in knockout models |
Electrophysiology
Patch-clamp recordings measure excitatory postsynaptic currents (EPSCs) to quantify synapse strength and number. This method is essential for assessing the functional impact of negative regulation of excitatory synapse assembly [2, 5].
Imaging of Dendritic Spines
Two-photon or confocal microscopy of fluorescently labeled neurons allows visualization of dendritic spine density and morphology, providing structural correlates of synapse assembly.
RNA Sequencing and Transcriptomics
RNA-seq can identify gene expression changes in models of altered synapse regulation, such as in phenylketonuria mice or after genetic manipulation of key regulators.
Proteomics and Co-Immunoprecipitation
Co-IP and mass spectrometry can reveal protein complexes involved in negative regulation, such as GluN3A-GIT1-mTORC1 interactions.
How CRISPR Can Be Used to Study GO:1904890 negative regulation of excitatory synapse assembly
Knockout
CRISPR knockout of genes such as GRIN3A, PICK1, or SHANK1 can reveal their role in negative regulation of excitatory synapse assembly. For example, GRIN3A knockout increases mTORC1 signaling and synapse formation, confirming its inhibitory role.
Point Mutation
Introducing point mutations that disrupt specific protein interactions (e.g., GIT1 binding to mTORC1) allows precise dissection of molecular mechanisms without affecting overall protein levels.
Knock-in
Knock-in of disease-associated mutations, such as in SHANK1 or PICK1, can model human neurodevelopmental disorders and assess their impact on synapse regulation [4, 5].
Overexpression
Overexpression of negative regulators like GluN3A or Fhod3 can suppress excitatory synapse assembly, providing gain-of-function models to study downstream effects [2, 6].
How EDITGENE Supports negative regulation of excitatory synapse assembly Research
Researchers studying negative regulation of excitatory synapse assembly-related genes often need to determine whether a candidate gene is causally involved in limiting synapse formation or whether it is merely correlated with synaptic changes. EDITGENE provides comprehensive CRISPR-based services to generate precise cellular and animal models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of excitatory synapse assembly research.
Frequently Asked Questions About negative regulation of excitatory synapse assembly
What is GO:1904890?
GO:1904890 is a Gene Ontology term for negative regulation of excitatory synapse assembly, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of excitatory synapse assembly.
What genes are involved in negative regulation of excitatory synapse assembly?
Key genes include GRIN3A, GIT1, MTOR, SHANK1, PICK1, FHOD3, and CLMP, among others [2, 4, 5, 6, 8].
How does GluN3A regulate excitatory synapse assembly?
GluN3A-containing NMDA receptors inhibit the assembly of GIT1/mTORC1 complexes, reducing protein synthesis and limiting synapse formation.
What diseases are associated with dysregulation of excitatory synapse assembly?
Alzheimer's disease, epilepsy, neurodevelopmental disorders, and phenylketonuria have been linked to altered synapse regulation [3, 7, 8].
What research methods are used to study negative regulation of excitatory synapse assembly?
Common methods include patch-clamp electrophysiology, dendritic spine imaging, RNA-seq, and co-immunoprecipitation [2, 5, 6, 7].
How can CRISPR be used to study this process?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of candidate genes to test their role in synapse regulation [2, 4, 5].
What is the role of PICK1 in excitatory synapse assembly?
PICK1 mediates synaptic recruitment of AMPA receptors; its downregulation reduces excitatory synapse strength.
How does Shank1 contribute to synapse regulation?
Shank1 mRNA transport and translation are controlled by its 5'UTR, affecting the availability of Shank1 protein at synapses and thus synapse stability.
Is negative regulation of excitatory synapse assembly important for memory?
Yes, it modulates protein synthesis and synaptic plasticity, which are essential for memory formation.
What model organisms are used to study this process?
Mouse models, particularly knockout and knock-in lines, are widely used, along with primary neuronal cultures [2, 5, 6, 8].
Conclusion
Negative regulation of excitatory synapse assembly (GO:1904890) is a critical biological process that prevents excessive excitatory connectivity and enables proper neural circuit refinement. Key molecular players such as GluN3A, GIT1, mTORC1, PICK1, and Shank1 have been identified, and their dysregulation is linked to neurological disorders including Alzheimer's disease and epilepsy. Continued research using advanced CRISPR models and multi-omics approaches will further elucidate the mechanisms and therapeutic potential of this process.
References
- 1. Duveau V et al.. 2011. Spatiotemporal specificity of GABAA receptor-mediated regulation of adult hippocampal neurogenesis.. Eur J Neurosci 34(3):362-73 PMID: 21722213
- 2. Conde-Dusman MJ et al.. 2021. Control of protein synthesis and memory by GluN3A-NMDA receptors through inhibition of GIT1/mTORC1 assembly.. Elife 10 PMID: 34787081
- 3. Palop JJ et al.. 2010. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks.. Nat Neurosci 13(7):812-8 PMID: 20581818
- 4. Falley K et al.. 2009. Shank1 mRNA: dendritic transport by kinesin and translational control by the 5'untranslated region.. Traffic 10(7):844-57 PMID: 19416473
- 5. Xu J et al.. 2014. PICK1 mediates synaptic recruitment of AMPA receptors at neurexin-induced postsynaptic sites.. J Neurosci 34(46):15415-24 PMID: 25392508
- 6. Sulistomo HW et al.. 2021. Fhod3 Controls the Dendritic Spine Morphology of Specific Subpopulations of Pyramidal Neurons in the Mouse Cerebral Cortex.. Cereb Cortex 31(4):2205-2219 PMID: 33251537
- 7. Hong S et al.. 2021. Gene expression profiles in the brain of phenylketonuria mouse model reversed by the low phenylalanine diet therapy.. Metab Brain Dis 36(8):2405-2414 PMID: 34524592
- 8. Jang S et al.. 2020. Clmp Regulates AMPA and Kainate Receptor Responses in the Neonatal Hippocampal CA3 and Kainate Seizure Susceptibility in Mice.. Front Synaptic Neurosci 12:567075 PMID: 33408624
